BioSpace News Archive

Business

Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors

Repligen Corporation (NASDAQ:RGEN) today announced the appointment of life sciences industry executive Rohin Mhatre, Ph.D., to its Board of Directors.

February 27, 2020

·

3 min read

Business

Avadel Pharmaceuticals to Report Fourth Quarter and Year End 2019 Financial Results on March 12th

Avadel Pharmaceuticals plc announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 12, 2020, to provide a corporate update and discuss the Company’s financial results for the fourth quarter and year ended December 31, 2019..

February 27, 2020

·

2 min read

Lone Star Bio

CNS Pharmaceuticals to Ring Nasdaq Stock Market Opening Bell on March 3

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”) today announced the Company’s Chief Executive Officer John Climaco will ring the opening bell of The Nasdaq Stock Market on Tuesday, March 3, 2020, at 9:30 a.m. Eastern time.

February 27, 2020

·

3 min read

Business

Promises Behavioral Health Chairman, Rob Waggener, Adds Interim CEO Responsibilities

Promises Behavioral Health, a growing national provider of comprehensive behavioral health, substance use disorder treatment and related services, announced that its Chairman, Rob Waggener, will take on the added responsibilities of interim Chief Executive Officer.

February 27, 2020

·

2 min read

Drug Development

Clene Nanomedicine Presents Blinded Interim Data from the VISIONARY-MS Phase 2 Study

Presentation today during Joint NAIMS-IMSVISUAL Symposium at ACTRIMS Forum 2020 Results demonstrate well-tolerated safety profile and notable preliminary trends of improved low-contrast vision in addition to improvement in standard MS functional endpoints

February 27, 2020

·

6 min read

Drug Development

Neurimmune Announces the Initiation of a Phase 1 Study of NI006 for the Treatment of ATTR Cardiomyopathy

Neurimmune AG, the discoverer of aducanumab and cinpanemab, announced today enrollment of the first patient in a Phase 1 clinical trial to evaluate NI006 in transthyretin amyloid cardiomyopathy (ATTR cardiomyopathy).

February 27, 2020

·

2 min read

Genetown

Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into a common stock purchase agreement (the “Agreement”) of up to $30 million with Aspire Capital Fund, LLC (“Aspire Capital”).

February 27, 2020

·

5 min read

Biotech Bay

Arcadia Biosciences Receives U.S. Patent for High Fiber Wheat with Improved Yield

Arcadia Biosciences, Latest patent expands the company’s portfolio to include an allele that improves yield in high fiber, resistant starch wheat

February 27, 2020

·

3 min read

Business

Jason Povio Named Senior Vice President of Operations at Eagle Telemedicine

Former Health Executive, Povio Brings Deep Healthcare, Systems Engineering Experience to Eagle Team

February 27, 2020

·

2 min read

BioMidwest

Spaulding Clinical Research Awarded Five-Year Contract With FDA

Spaulding Clinical Research announced that it has been awarded a five-year contract with the U.S. Food and Drug Administration Division of Applied Regulatory Science to conduct multiple clinical trials in various therapeutic areas of interest.

February 27, 2020

·

1 min read